Galmed Pharmaceuticals (GLMD) Dividends Paid - Common Growth (1y) (2014 - 2023)
Galmed Pharmaceuticals (GLMD) Dividends Paid - Common Growth (1y) (2014 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 4.54% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -10.39% |
| 10 | Galmed Pharmaceuticals | 2.31 Mn | -9.57 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 351.79% |
| Mar 31, 2020 | -64.03% |
| Sep 30, 2019 | -137.75% |
| Jun 30, 2019 | -428.41% |
| Mar 31, 2019 | 1,319.16% |
| Sep 30, 2018 | 2,187.43% |
| Jun 30, 2018 | 3,945.98% |
| Mar 31, 2018 | 58.49% |
| Sep 30, 2017 | -78.80% |
| Jun 30, 2017 | 163.04% |
| Mar 31, 2017 | -46.17% |
| Sep 30, 2016 | 242.92% |
| Jun 30, 2016 | -102.77% |
| Mar 31, 2016 | 31.79% |
| Sep 30, 2015 | -39.09% |
| Jun 30, 2015 | 310.30% |
| Mar 31, 2015 | -94.12% |
| Sep 30, 2014 | -1,385.63% |
| Jun 30, 2014 | -1,319.16% |
| Mar 31, 2014 | 15,314.34% |